SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Basilea Pharmaceutica Reports Recruitment Completion of Phase 3 Pivotal Study of Isavuconazole, an Agent for the Potential Primary Treatment of Invasive and Life-Threatening Fungal Infections